Ligand-based drug design combines AI and QSAR modeling to prioritize drug candidates, minimizing preclinical failures and ...
Background Joint analyses across multiple health datasets can increase statistical power and improve the generalisability of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results